BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 25565956)

  • 21. Mesenchymal stem cells stabilize the blood-brain barrier through regulation of astrocytes.
    Park HJ; Shin JY; Kim HN; Oh SH; Song SK; Lee PH
    Stem Cell Res Ther; 2015 Sep; 6():187. PubMed ID: 26420371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
    Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
    J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High uptake of
    Oliveira D; Stegmayr C; Heinzel A; Ermert J; Neumaier B; Shah NJ; Mottaghy FM; Langen KJ; Willuweit A
    EJNMMI Res; 2020 May; 10(1):55. PubMed ID: 32451793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model.
    Yamada K; Ushio Y; Hayakawa T; Kato A; Yamada N; Mogami H
    J Neurosurg; 1982 Sep; 57(3):394-8. PubMed ID: 7097336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular Abnormalities and the Role of Vascular Endothelial Growth Factor in the Epileptic Brain.
    Ogaki A; Ikegaya Y; Koyama R
    Front Pharmacol; 2020; 11():20. PubMed ID: 32116699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-α and IL-6 in an iPSC-based blood-brain barrier model.
    Mantle JL; Lee KH
    Neurobiol Dis; 2018 Nov; 119():113-120. PubMed ID: 30075293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive Astrocytes in Glioblastoma Multiforme.
    Guan X; Hasan MN; Maniar S; Jia W; Sun D
    Mol Neurobiol; 2018 Aug; 55(8):6927-6938. PubMed ID: 29363044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioma and glioblastoma - how much do we (not) know?
    Jovčevska I; Kočevar N; Komel R
    Mol Clin Oncol; 2013 Nov; 1(6):935-941. PubMed ID: 24649273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier.
    Grabb PA; Gilbert MR
    J Neurosurg; 1995 Jun; 82(6):1053-8. PubMed ID: 7760177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.
    Dréan A; Goldwirt L; Verreault M; Canney M; Schmitt C; Guehennec J; Delattre JY; Carpentier A; Idbaih A
    Expert Rev Neurother; 2016 Nov; 16(11):1285-1300. PubMed ID: 27310463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
    Sarkaria JN; Hu LS; Parney IF; Pafundi DH; Brinkmann DH; Laack NN; Giannini C; Burns TC; Kizilbash SH; Laramy JK; Swanson KR; Kaufmann TJ; Brown PD; Agar NYR; Galanis E; Buckner JC; Elmquist WF
    Neuro Oncol; 2018 Jan; 20(2):184-191. PubMed ID: 29016900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Endothelin ET
    Michinaga S
    Yakugaku Zasshi; 2017; 137(10):1241-1246. PubMed ID: 28966265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual Roles of Astrocyte-Derived Factors in Regulation of Blood-Brain Barrier Function after Brain Damage.
    Michinaga S; Koyama Y
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphofunctional aspects of the blood-brain barrier.
    Nico B; Ribatti D
    Curr Drug Metab; 2012 Jan; 13(1):50-60. PubMed ID: 22292807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electron microscopy of the blood-brain barrier in disease.
    Hirano A; Kawanami T; Llena JF
    Microsc Res Tech; 1994 Apr; 27(6):543-56. PubMed ID: 8012057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
    Salaroglio IC; Abate C; Rolando B; Battaglia L; Gazzano E; Colombino E; Costamagna C; Annovazzi L; Mellai M; Berardi F; Capucchio MT; Schiffer D; Riganti C
    Mol Pharm; 2019 Aug; 16(8):3361-3373. PubMed ID: 31265310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients.
    García-Romero N; Carrión-Navarro J; Esteban-Rubio S; Lázaro-Ibáñez E; Peris-Celda M; Alonso MM; Guzmán-De-Villoria J; Fernández-Carballal C; de Mendivil AO; García-Duque S; Escobedo-Lucea C; Prat-Acín R; Belda-Iniesta C; Ayuso-Sacido A
    Oncotarget; 2017 Jan; 8(1):1416-1428. PubMed ID: 27902458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.
    Cooper I; Last D; Guez D; Sharabi S; Elhaik Goldman S; Lubitz I; Daniels D; Salomon S; Tamar G; Tamir T; Mardor R; Fridkin M; Shechter Y; Mardor Y
    J Cereb Blood Flow Metab; 2015 Jun; 35(6):967-76. PubMed ID: 25669901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistochemical investigation of serum proteins in human brain gliomas].
    Li NY
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):45-7. PubMed ID: 1327689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.